Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Price | 1d % | 1w % | 1m % | 3m % | 6m % | 1y % | 3y % | 5y % | 10y % | 52-week High | 52-week Low | % off 52-week High | % off 52-week Low | Beta | Volume | Vol 1d % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SLNO | SOLENO THERAPEUTICS INC | $33.48 | 9.99% | 6.83% | -14.29% | -27.69% | -50.47% | -53.14% | 1,464.49% | 77.14% | -62.46% | $90.32 | $29.43 | 62.93% | 13.76% | 0.41 | 3,032,000 | 119.87% |
| ALNY | ALNYLAM PHARMACEUTICALS INC | $330.87 | 4.68% | 7.41% | 1.78% | -16.79% | -27.44% | 22.54% | 65.17% | 134.34% | 427.11% | $495.55 | $205.87 | 33.23% | 60.72% | 0.89 | 1,352,000 | 13.04% |
| ZVRA | ZEVRA THERAPEUTICS INC | $9.32 | 6.15% | 1.86% | 2.53% | 4.02% | -2.00% | 24.43% | 69.45% | 1.30% | -95.98% | $13.16 | $6.19 | 29.18% | 50.57% | 0.88 | 920,000 | 5.02% |
| ADMA | ADMA BIOLOGICS INC | $9.01 | -1.53% | -20.48% | -45.66% | -50.60% | -38.54% | -54.59% | 172.21% | 411.93% | 11.37% | $25.67 | $7.21 | 64.90% | 24.97% | 1.22 | 6,979,000 | -7.93% |
| CORT | CORCEPT THERAPEUTICS INC | $40.31 | 5.75% | 19.19% | 12.07% | 15.83% | -51.50% | -64.71% | 86.10% | 69.44% | 761.32% | $91.00 | $28.66 | 55.70% | 40.65% | 0.96 | 1,502,000 | -22.14% |
| ABEO | ABEONA THERAPEUTICS INC | $4.48 | 5.91% | 3.46% | -11.46% | -14.99% | -15.15% | -5.88% | 58.87% | -90.47% | -93.00% | $7.54 | $3.93 | 40.58% | 13.91% | 0.88 | 1,095,000 | 26.01% |
| HALO | HALOZYME THERAPEUTICS INC | $64.63 | 4.02% | 4.17% | -7.47% | -3.97% | -11.88% | 1.29% | 69.23% | 55.03% | 582.47% | $82.22 | $47.50 | 21.39% | 36.06% | 0.80 | 1,459,000 | 43.18% |
| KRYS | KRYSTAL BIOTECH INC | $258.32 | 4.61% | 4.54% | -0.19% | 4.78% | 46.33% | 43.27% | 222.66% | 235.31% | N/A | $298.30 | $122.80 | 13.40% | 110.36% | 1.33 | 294,000 | -29.16% |
| NAGE | NIAGEN BIOSCIENCE INC | $4.41 | 3.04% | -2.86% | -11.62% | -30.66% | -52.73% | -36.09% | 188.24% | -52.78% | 3.52% | $14.69 | $4.16 | 69.98% | 6.01% | 1.51 | 702,000 | -10.12% |
| RPRX | ROYALTY PHARMA PLC | $47.97 | 3.45% | 5.27% | 1.05% | 24.15% | 35.97% | 54.10% | 33.14% | 9.97% | N/A | $47.98 | $29.66 | 0.02% | 61.73% | 0.47 | 3,216,000 | 49.44% |
| VCEL | VERICEL CORP | $32.17 | 5.30% | -2.75% | -9.02% | -10.66% | 2.22% | -27.90% | 9.72% | -42.09% | 448.98% | $45.97 | $28.95 | 30.02% | 11.12% | 1.49 | 951,000 | 3.82% |
| APLS | APELLIS PHARMACEUTICALS INC | $40.23 | 135.40% | 133.49% | 94.35% | 60.15% | 77.77% | 83.95% | -39.01% | -6.25% | N/A | $40.45 | $16.10 | 0.54% | 149.88% | 1.25 | 89,848,000 | 4,071.22% |
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $28.01 | 4.13% | 3.36% | -3.08% | -25.15% | 1.63% | -15.61% | -14.21% | -15.22% | N/A | $40.87 | $25.52 | 31.47% | 9.76% | 0.84 | 766,000 | 24.96% |
| MNKD | MANNKIND CORP | $2.45 | 3.38% | 6.99% | -19.28% | -56.79% | -54.38% | -51.29% | -40.24% | -37.50% | -69.57% | $6.51 | $2.23 | 62.37% | 9.87% | 1.09 | 4,801,000 | -11.97% |
| TECH | BIO-TECHNE CORP | $52.26 | 0.42% | -0.32% | -9.62% | -11.14% | -6.06% | -10.86% | -29.56% | -45.27% | 121.16% | $72.16 | $46.01 | 27.58% | 13.58% | 1.16 | 2,537,000 | 47.50% |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $56.49 | 3.10% | 4.44% | -5.44% | -4.95% | 4.30% | -20.09% | -41.91% | -25.19% | -31.51% | $69.87 | $50.76 | 19.15% | 11.29% | 0.72 | 2,476,000 | 148.10% |
| EXEL | EXELIXIS INC | $42.89 | 2.24% | 3.18% | 4.53% | -2.14% | 3.85% | 16.17% | 120.97% | 89.86% | 972.25% | $49.62 | $32.38 | 13.56% | 32.46% | 0.60 | 1,883,000 | -10.46% |
| VCYT | VERACYTE INC | $32.21 | 5.81% | -2.22% | -10.55% | -23.49% | -6.18% | 8.63% | 44.44% | -40.07% | 496.48% | $50.71 | $22.61 | 36.48% | 42.46% | 1.91 | 1,050,000 | -20.69% |
| XOMA | XOMA ROYALTY CORP | $31.37 | 3.70% | 7.36% | 19.69% | 17.98% | -18.60% | 57.40% | 48.60% | -23.13% | 102.91% | $39.92 | $18.35 | 21.42% | 70.94% | 0.80 | 124,000 | 63.16% |
| REGN | REGENERON PHARMACEUTICALS INC | $772.64 | 3.12% | 4.17% | -2.30% | 0.10% | 37.41% | 21.82% | -5.97% | 63.30% | 114.36% | $821.11 | $476.49 | 5.90% | 62.15% | 0.60 | 642,000 | 8.08% |
| CPRX | CATALYST PHARMACEUTICALS INC | $24.76 | 4.12% | 7.33% | 3.69% | 6.08% | 25.69% | 2.10% | 49.34% | 437.09% | 2,016.24% | $26.58 | $19.05 | 6.85% | 29.97% | 1.03 | 953,000 | 26.73% |
| VRTX | VERTEX PHARMACEUTICALS INC | $446.54 | 0.76% | -0.46% | -8.13% | -1.50% | 14.02% | -7.90% | 41.73% | 107.80% | 461.76% | $510.77 | $362.50 | 12.58% | 23.18% | 0.57 | 1,624,000 | -13.34% |
| LGND | LIGAND PHARMACEUTICALS INC | $199.65 | 3.64% | -1.00% | -1.43% | 5.60% | 12.71% | 89.89% | 171.41% | 30.96% | 86.43% | $227.92 | $93.58 | 12.40% | 113.35% | 1.14 | 191,000 | -9.91% |
| UTHR | UNITED THERAPEUTICS CORP | $592.98 | 0.79% | 11.50% | 15.41% | 21.70% | 41.45% | 92.36% | 164.77% | 254.50% | 432.15% | $607.89 | $266.98 | 2.45% | 122.11% | 0.42 | 965,000 | -42.08% |
| INCY | INCYTE CORP | $94.12 | 4.20% | 3.86% | -5.92% | -4.71% | 10.98% | 55.44% | 30.23% | 15.81% | 29.87% | $112.29 | $53.56 | 16.18% | 75.73% | 0.55 | 1,754,000 | 20.88% |
| CRMD | CORMEDIX INC | $6.79 | 3.35% | 5.11% | -5.83% | -41.62% | -41.62% | 10.23% | 64.01% | -32.03% | -48.75% | $17.43 | $5.60 | 61.04% | 21.25% | 1.09 | 1,237,000 | -2.29% |
| MDXG | MIMEDX GROUP INC | $3.95 | 2.33% | -4.36% | -19.06% | -41.65% | -43.41% | -48.03% | 15.84% | -61.65% | -54.81% | $7.99 | $3.77 | 50.56% | 4.77% | 1.29 | 1,552,000 | 71.30% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.